Estatísticas Básicas
| LEI | 549300RJ8LY41HS70C91 |
| CIK | 914156 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to UFP Technologies, Inc.
SEC Filings (Chronological Order)
Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.
| June 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| May 29, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 100 Hale Street, Newburyport Massachusetts 01950-3504 (Address of Princip |
|
| May 29, 2026 |
UFP Technologies, Inc. Conflict Minerals Report Exhibit 1.01 UFP Technologies, Inc. Conflict Minerals Report 2025 Introduction This Conflict Minerals Report (“CMR”) of UFP Technologies, Inc. (herein referred to as “UFP,” the “Company,” “we,” “us,” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, as amended (“Exchange Act”), for the reporting period from January 1, 2025 to Dece |
|
| May 26, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| May 8, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2026 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techn |
|
| May 4, 2026 |
UFP Technologies Announces Strong Q1 Results Exhibit 99.1 UFP Technologies Announces Strong Q1 Results Newburyport, Mass., May 4, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.5 million for its first quarter ended March 31, 2026, 1.8% higher than net income of $17.2 million for the first qua |
|
| May 4, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 30, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☒ Defin |
|
| April 30, 2026 |
Developed for Customers. Growing with Purpose. 2025 ANNUAL REPORTUFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and sterile packaging for minimally invasive surgery, infection prevent |
|
| February 27, 2026 |
ufptechnologiesinvestord Welcome Investors March 2026 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. |
|
| February 27, 2026 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 23.01 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our reports dated February 27th, 2026, with respect to the consolidated financial statements and internal control over financial reporting in the Annual Report of UFP Technologies, Inc. on Form 10-K for the year ended December 31, 2025. We consent to the incorporation by reference of said reports in the Registrat |
|
| February 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12648 UFP Tec |
|
| February 27, 2026 |
Exhibit 19.0 UFP TECHNOLOGIES, INC. POLICY STATEMENT ON SECURITIES TRADES BY COMPANY OFFICERS, DIRECTORS AND OTHER EMPLOYEES Adopted by the Board of Directors on March 12, 2025 Introduction In the normal course of business, employees, officers and directors of UFP Technologies, Inc., a Delaware corporation (the “Company”), may use or have access to confidential and material information that is not |
|
| February 27, 2026 |
Exhibit 32.01 CERTIFICATION Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of UFP Technologies, Inc., a Delaware corporation (the “Co |
|
| February 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 27, 2026 |
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 31.01 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, R. Jeffrey Bailly, Chief Executive Officer of UFP Technologies, Inc., certify that: 1.I have reviewed this Annual Report on Form 10-K of UFP Technologies, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the s |
|
| February 27, 2026 |
UFP Technologies, Inc. wholly owns the following companies: Exhibit 21.01 UFP Technologies, Inc. wholly owns the following companies: 1.Advant Medical Limited, a private limited company incorporated under the laws of Ireland, and its wholly-owned subsidiary: a.Munlu Leighis Advant Teoranta, a private limited company incorporated under the laws of Ireland 2.Advant Costa Rica Limitada, incorporated under the laws of Costa Rica 3.Simco Industries, Inc., a Mic |
|
| February 27, 2026 |
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 31.02 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ronald J. Lataille, Chief Financial Officer of UFP Technologies, Inc., certify that: 1.I have reviewed this Annual Report on Form 10-K of UFP Technologies, Inc.; 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the |
|
| February 24, 2026 |
AMENDMENT NO. 27 TO MANUFACTURING SUPPLY AGREEMENT Exhibit 10.1 AMENDMENT NO. 27 TO MANUFACTURING SUPPLY AGREEMENT This amendment to the Manufacturing Supply Agreement (the “Amendment No. 27”) is dated January 1, 2026 (the “Amendment No. 27 Effective Date”) and is between INTUITIVE SURGICAL SARL, a Swiss corporation located at 1 Chemin des Muriers, 1170 Aubonne, Switzerland (“Intuitive”) and DAS MEDICAL INTERNATIONAL SRL (A SUBSIDIARY OF DAS MEDIC |
|
| February 24, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 24, 2026 |
UFP Technologies Announces Record 2025 Results Exhibit 99.1 UFP Technologies Announces Record 2025 Results Newburyport, Mass., February 24, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $7 |
|
| February 24, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 24, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 13, 2026 |
STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) Exhibit 10.3 STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 10th day of February, 2026 by and between UFP Technologies, Inc. (hereinafter the “Company”) and R Jeffrey Bailly (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company’s 2003 |
|
| February 13, 2026 |
STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) Exhibit 10.4 STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 10th day of February, 2026 by and between UFP Technologies, Inc. (hereinafter the “Company”) and (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company’s 2003 Incentive Plan, |
|
| February 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2026 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 13, 2026 |
Exhibit 10.5 CERTAIN INFORMATION, IDENTIFIED BY, AND REPLACED WITH, A MARK OF “[**]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL. UFP TECHNOLOGIES, INC. 2026 FORM OF PERFORMANCE SHARE AGREEMENT (3-Year Performance Period) February 10, 2026 On February 10, 2026 UFP Technologies, Inc. |
|
| February 13, 2026 |
Exhibit 10.2 EXECUTIVE SEVERANCE AGREEMENT THIS EXECUTIVE SEVERANCE AGREEMENT (“Severance Agreement”) by and between UFP Technologies, Inc., a Delaware corporation (the “Company”) and Mitchell C. Rock (the “Executive”) is made as of February 10, 2026, to take effect as of June 4, 2026 (the “Effective Date”). WHEREAS, the Executive and the Company have executed an offer letter dated February 10, 20 |
|
| February 13, 2026 |
100 Hale Street, Newburyport, MA 01950 USA | tel. 978-352-2200 | www.ufpt.com Exhibit 10.1 CERTAIN INFORMATION, IDENTIFIED BY, AND REPLACED WITH, A MARK OF “[**]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL. February 10, 2026 Mitch Rock [**] [**] Dear Mitch, Congratulations! On behalf of UFP Technologies, it is my pleasure to extend this offer of promotion to |
|
| December 2, 2025 |
UFP Technologies Announces CEO Succession Plan UFP Technologies, Inc. www.ufpt.com 100 Hale Street Contact: Ron Lataille Newburyport, MA 01950 USA 978-234-0926, [email protected] FOR IMMEDIATE RELEASE UFP Technologies Announces CEO Succession Plan Newburyport, Mass., December 2, 2025. UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, |
|
| December 2, 2025 |
ufptechnologiesinvestord Welcome Investors December 2025 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. |
|
| December 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2025 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| December 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2025 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| November 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP T |
|
| November 3, 2025 |
UFP Technologies Announces Strong Q3 2025 Results EXHIBIT 99.1 UFP Technologies Announces Strong Q3 2025 Results Newburyport, Mass., November 3, 2025. UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $16.4 million or $2.11 per diluted common share outstanding for its third quarter ended September 30, 2025, th |
|
| November 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2025 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| September 5, 2025 |
144 0001193968 XXXXXXXX LIVE 0000914156 UFP Technologies Inc 001-12648 100 Hale Street Newburyport MA 01950 9783522200 The Daniel C. |
|
| August 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 21, 2025 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File |
|
| August 21, 2025 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors August 2025 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’s future fin |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techno |
|
| August 5, 2025 |
UFP Technologies Announces Record Q2 Results EXHIBIT 99.1 UFP Technologies Announces Record Q2 Results NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 20 |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2025 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| July 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 17, 2025 |
UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities EXHIBIT 99.1 UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastic |
|
| June 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 10, 2025 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File N |
|
| June 10, 2025 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors June 2025 Forward Looking Statements 2 Some of the statements contained in this Report are forward - looking statements within the meaning of Section 27A of the Securiti es Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). Management and representatives of UFP Technologies, Inc. |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 4, 2025 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File Nu |
|
| May 30, 2025 |
Exhibit 1.01 UFP Technologies, Inc. Conflict Minerals Report 2024 Introduction This Conflict Minerals Report (“CMR”) of UFP Technologies, Inc. (herein referred to as “UFP,” the “Company,” “we,” “us,” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, as amended (“Exchange Act”), for the reporting period from January 1, 2024 to Dece |
|
| May 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 100 Hale Street, Newburyport Massachusetts 01950 (Address of Principal Ex |
|
| May 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techn |
|
| May 7, 2025 |
UFP Technologies Announces Record Q1 Results EXHIBIT 99.1 UFP Technologies Announces Record Q1 Results NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☒ Defin |
|
| April 29, 2025 |
Optimizing Our Platform for Growth 2024 ANNUAL REPORT UFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world. |
|
| April 4, 2025 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2025 UFP Technologies, Inc. |
|
| April 4, 2025 |
Exhibit 10.2 Certain identified information has been excluded because it is both not material and would be competitively harmful if publicly disclosed. These redacted terms have been marked in this exhibit at the appropriate places with the three asterisks [***]. Stryker Medical - Sage Global Quality and Operations Sage Products, LLC 3909 Three Oaks Rd Cary, Illinois 60013 AJR Enterprises, LLC. At |
|
| April 4, 2025 |
Supplier Letter Agreement between Sage Products, LLC and AJR Enterprises, LLC, dated March 31, 2025. Exhibit 10.1 Certain identified information has been excluded because it is both not material and would be competitively harmful if publicly disclosed. These redacted terms have been marked in this exhibit at the appropriate places with the three asterisks [***]. Stryker Medical - Sage Global Quality and Operations Sage Products, LLC 3909 Three Oaks Rd Cary, Illinois 60013 AJR Enterprises, LLC. At |
|
| March 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2025 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| March 3, 2025 |
Exhibit 31.02 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ronald J. Lataille, Chief Financial Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this Annual Report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make th |
|
| March 3, 2025 |
Exhibit 32.01 CERTIFICATION Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of UFP Technologies, Inc., a Delaware corporation (the “Co |
|
| March 3, 2025 |
Consent of Grant Thornton LLP. * Exhibit 23.01 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our reports dated March 3, 2025, with respect to the consolidated financial statements and internal control over financial reporting in the Annual Report of UFP Technologies, Inc. on Form 10-K for the year ended December 31, 2024. We consent to the incorporation by reference of said reports in the Registration St |
|
| March 3, 2025 |
Subsidiaries of the Company. * Exhibit 21.01 UFP Technologies, Inc. wholly owns the following companies: 1. Advant Medical Limited, a private limited company incorporated under the laws of Ireland, and its wholly-owned subsidiary: a. Munlu Leighis Advant Teoranta, a private limited company incorporated under the laws of Ireland 2. Advant Costa Rica Limitada, incorporated under the laws of Costa Rica 3. Advant Medical Inc., a De |
|
| March 3, 2025 |
Exhibit 31.01 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, R. Jeffrey Bailly, Chief Executive Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this Annual Report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12648 UFP Technologies, Inc. (E |
|
| March 3, 2025 |
Exhibit 19.0 UFP TECHNOLOGIES, INC. POLICY STATEMENT ON SECURITIES TRADES BY COMPANY OFFICERS, DIRECTORS AND OTHER EMPLOYEES Adopted by the Board of Directors on March 13, 2024 Introduction In the normal course of business, employees, officers and directors of UFP Technologies, Inc., a Delaware corporation (the “Company”), may use or have access to confidential and material information that is not |
|
| February 25, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2025 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 25, 2025 |
UFP Technologies Announces Record 2024 Results EXHIBIT 99.1 UFP Technologies Announces Record 2024 Results NEWBURYPORT, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported 2024 net income of $59.0 million, 31.3% higher than net income of $44.9 million for 2023. Adjusted net income grew 32.5% to $67.6 million. N |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2025 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commissio |
|
| February 18, 2025 |
Form of 2025 CEO Stock Unit Award Agreement. Exhibit 10.1 STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 11th day of February, 2025 by and between UFP Technologies, Inc. (hereinafter the “Company”) and R. Jeffrey Bailly (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company’s 200 |
|
| February 18, 2025 |
Form of 2025 Stock Unit Award Agreement. Exhibit 10.2 STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 11th day of February, 2025 by and between UFP Technologies, Inc. (hereinafter the “Company”) and (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company’s 2003 Incentive Plan, |
|
| November 13, 2024 |
UFPT / UFP Technologies, Inc. / WASATCH ADVISORS INC Passive Investment SC 13G 1 ufpt1124.txt SCHEDULE 13G Amendment No. Name of Issuer: UFP Technologies, Inc. Title of Class of Securities: Common Stock CUSIP Number: 902673102 Item 1: Reporting Person: Wasatch Advisors LP 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 420,549 Item 6: |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| November 12, 2024 |
UFP Technologies Announces Record Q3 2024 Results EXHIBIT 99.1 UFP Technologies Announces Record Q3 2024 Results NEWBURYPORT, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported that net income increased 40% to $16.4 million in the third quarter of 2 |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP T |
|
| August 26, 2024 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors August 2024 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’ s future fi |
|
| August 26, 2024 |
UFP Technologies Acquires AQF Medical EXHIBIT 99.1 UFP Technologies Acquires AQF Medical NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited (“AQF Medical”). Headquartered in Navan, Ireland with additiona |
|
| August 26, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| August 26, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 26, 2024 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techno |
|
| August 2, 2024 |
UFP Technologies Announces Record Q2 Results EXHIBIT 99.1 UFP Technologies Announces Record Q2 Results NEWBURYPORT, Mass., July 31, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $13.6 million or $1.75 per diluted common share outstanding for its second quarter end |
|
| August 2, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 16, 2024 |
UFP Technologies Acquires Marble Medical EXHIBIT 99.2 UFP Technologies Acquires Marble Medical NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Ma |
|
| July 16, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 16, 2024 |
UFP Technologies Acquires Welch Fluorocarbon EXHIBIT 99.1 UFP Technologies Acquires Welch Fluorocarbon NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Welch Fluorocarbon Inc. Founded in 1985 and headquartered in Dover, |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 1, 2024 |
UFP Technologies Acquires AJR Enterprises EXHIBIT 99.1 UFP Technologies Acquires AJR Enterprises NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with addi |
|
| July 1, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is made as of July 1, 2024 (the “Effective Date”), by and among UFP Technologies, Inc., a Delaware corporation (“Buyer”), AJR Enterprises, LLC, a Delaware limited liability company (the “Company”), each Person set forth on Schedule A (each, “Seller,” and collectively, “Sellers”), each Person incl |
|
| July 1, 2024 |
Exhibit 10.2 THIRD AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 27, 2024 among UFP TECHNOLOGIES, INC., as Borrower, CERTAIN SUBSIDIARIES OF UFP TECHNOLOGIES, INC. PARTY HERETO, as Guarantors, BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and THE LENDERS PARTY HERETO BANK OF AMERICA, N.A., as Sole Lead Arranger and Sole Bookru |
|
| June 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 11, 2024 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File N |
|
| June 11, 2024 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors June 2024 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’ s future fina |
|
| June 7, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 5, 2024 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File Nu |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 100 Hale Street, Newburyport Massachusetts 01950 (Address of Principal Ex |
|
| June 3, 2024 |
Exhibit 1.01 UFP Technologies, Inc. Conflict Minerals Report Introduction This Conflict Minerals Report (“CMR”) of UFP Technologies, Inc. (herein referred to as “UFP,” the “Company,” “we,” “us,” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, as amended (“Exchange Act”), for the reporting period from January 1, 2023 to December |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techn |
|
| May 1, 2024 |
UFP Technologies Announces Record Q1 Results EXHIBIT 99.1 UFP Technologies Announces Record Q1 Results NEWBURYPORT, Mass., May 01, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $12.7 million or $1.64 per diluted common share outstanding for its first quarter ended March 31, 2024, compared to net income |
|
| May 1, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 29, 2024 |
2023 Annual Report CUSTOMER-FOCUSED STRATEGIC GROWTH 100565Cvr.indd 2 100565Cvr.indd 2 4/17/24 3:32 PM 4/17/24 3:32 PM100565Cvr.indd 3 100565Cvr.indd 3 4/17/24 3:32 PM 4/17/24 3:32 PMUFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device sup |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☒ Defin |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 UFP Technologies, Inc. |
|
| March 18, 2024 |
Exhibit 10.1 Certain identified information has been excluded because it is both not material and would be competitively harmful if publicly disclosed. These redacted terms have been marked in this exhibit at the appropriate places with the three asterisks [***]. MANUFACTURING SUPPLY AGREEMENT This manufacturing supply agreement ("Agreement") is dated April 25, 2014 ("Effective Date"), and is betw |
|
| March 18, 2024 |
Exhibit 10.2 Certain identified information has been excluded because it is both not material and would be competitively harmful if publicly disclosed. These redacted terms have been marked in this exhibit at the appropriate places with the three asterisks [***]. Amendment No. 24 to MANUFACTURING SUPPLY AGREEMENT This amendment to the Manufacturing Supply Agreement (the “Amendment No. 24”) is date |
|
| March 8, 2024 |
UFPT / UFP Technologies, Inc. / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-03082024080320.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* UFP TECHNOLOGIES INC (Name of Issuer) COMMON (Title of Class of Securities) 902673102 (CUSIP Number) February 29, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 29, 2024 |
Exhibit 31.02 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ronald J. Lataille, Chief Financial Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this Annual Report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make th |
|
| February 29, 2024 |
Form of 2023 Stock Unit Award Agreement (Dominican Republic) #* Exhibit 10.23 Exhibit F STOCK UNIT AWARD AGREEMENT (Dominican Republic Employees) (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 14th day of February, 2023 by and between UFP Technologies, Inc. (hereinafter the “Company”) and (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to t |
|
| February 29, 2024 |
Consent of Grant Thornton LLP. * Exhibit 23.01 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our reports dated February 29, 2024, with respect to the consolidated financial statements and internal controls over financial reporting in the Annual Report of UFP Technologies, Inc. on Form 10-K for the year ended December 31, 2023. We consent to the incorporation by reference of said reports in the Registrati |
|
| February 29, 2024 |
Subsidiaries of the Company. * Exhibit 21.01 UFP Technologies, Inc. wholly owns the following companies: 1. Advant Medical Limited, a private limited company incorporated under the laws of Ireland, its wholly-owned subsidiary: a. Munlu Leighis Advant Teoranta, a private limited company incorporated under the laws of Ireland 2. Advant Costa Rica Limitada, incorporated under the laws of Costa Rica 3. Advant Medical Inc., a Delawa |
|
| February 29, 2024 |
Description of Company Securities * Exhibit 4.02 DESCRIPTION OF COMPANY SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 This section summarizes certain information regarding the Common Stock, $0.01 par value per share (the “Common Stock”), of UFP Technologies, Inc., a Delaware corporation (“we”, “us”, “our” or the “Company”), which constitutes the only class of the Company’s securities that is reg |
|
| February 29, 2024 |
Policy for the Recovery of Erroneously Awarded Compensation. * Exhibit 97.1 Policy GOV.03 Policy for the Recovery of Erroneously Awarded Compensation TABLE OF CONTENTS Overview 2 Policy Statement 2 Disclosure Requirements 2 Prohibition of Indemnification 3 Policy Definitions 3 - 1 - OVERVIEW In accordance with the applicable rules of the Nasdaq Stock Market, Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (“the Exchange Act”), th |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12648 UFP Technologies, Inc. (E |
|
| February 29, 2024 |
Exhibit 32.01 CERTIFICATION Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of UFP Technologies, Inc., a Delaware corporation (the “Co |
|
| February 29, 2024 |
Exhibit 31.01 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, R. Jeffrey Bailly, President and Chief Executive Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this Annual Report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 26, 2024 |
UFP Technologies Announces Record 2023 Results EXHIBIT 99.1 UFP Technologies Announces Record 2023 Results NEWBURYPORT, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $44.9 million or $5.83 per diluted common share outstanding for its year ended December 31, 2023, compared to net income of $4 |
|
| February 26, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2024 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 13, 2024 |
UFPT / UFP Technologies, Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SC 13G 1 tv02139-ufptechnologiesinc.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: UFP Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 902673102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant |
|
| February 13, 2024 |
UFPT / UFP Technologies, Inc. / RENAISSANCE TECHNOLOGIES LLC Passive Investment SC 13G/A 1 ufpt-13g20231231.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15)* UFP Technologies, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) December 29, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d |
|
| February 12, 2024 |
UFPT / UFP Technologies, Inc. / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-02122024060242.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* UFP TECHNOLOGIES INC (Name of Issuer) COMMON (Title of Class of Securities) 902673102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 8, 2024 |
Exhibit 10.2 Exhibit B STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 6th day of February, 2024 by and between UFP Technologies, Inc. (hereinafter the “Company”) and (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company’s 2003 Incenti |
|
| February 8, 2024 |
Exhibit 10.1 Exhibit A STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 6th day of February, 2024 by and between UFP Technologies, Inc. (hereinafter the “Company”) and R. Jeffrey Bailly (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Comp |
|
| February 8, 2024 |
Mitchell Rock Named President of UFP Technologies EXHIBIT 99.1 Mitchell Rock Named President of UFP Technologies NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company. Rock has been serving as Preside |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 6, 2024 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commission |
|
| January 26, 2024 |
UFPT / UFP Technologies, Inc. / AltraVue Capital, LLC Passive Investment SC 13G/A 1 UFPT13GFINAL01232024.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* UFP Technologies, Inc. (Name of Issuer) Common (Title of Class of Securities) 902673102 (CUSIP Number) December 31st, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate |
|
| January 23, 2024 |
UFPT / UFP Technologies, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us9026731029012324.txt us9026731029012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) UFP TECHNOLOGIES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 28, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 28, 2023 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission Fi |
|
| November 28, 2023 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors November 2023 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’ s future |
|
| November 9, 2023 |
UFP Technologies Announces Strong Q3 2023 Results EXHIBIT 99.1 UFP Technologies Announces Strong Q3 2023 Results NEWBURYPORT, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported that adjusted net income increased 13.8% to $11.9 million in the third q |
|
| November 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP T |
|
| September 8, 2023 |
UFPT / UFP Technologies Inc. / Neuberger Berman Group LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* UFP TECHNOLOGIES INC (Name of Issuer) COMMON (Title of Class of Securities) 902673102 (CUSIP Number) August 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| August 21, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 21, 2023 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File |
|
| August 21, 2023 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors August 2023 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’ s future fi |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techno |
|
| August 4, 2023 |
UFP Technologies Announces Record Q2 Results EXHIBIT 99.1 UFP Technologies Announces Record Q2 Results NEWBURYPORT, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $11.9 million or $1.55 per diluted common share outstanding for its second quarter end |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2023 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| July 7, 2023 |
UFPT / UFP Technologies Inc. / BlackRock Inc. Passive Investment us9026731029070723.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) UFP TECHNOLOGIES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) June 30, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 13, 2023 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File N |
|
| June 13, 2023 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF UFP TECHNOLOGIES, INC. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware) UFP Technologies, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), DOES HEREBY CERTIFY: 1. That the |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 7, 2023 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File Nu |
|
| June 13, 2023 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors June 2023 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’ s future fina |
|
| June 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 12, 2023 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File N |
|
| June 12, 2023 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors June 2023 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Company’ s future fina |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 100 Hale Street, Newburyport Massachusetts 01950 (Address of Principal Ex |
|
| May 31, 2023 |
EX-1.01 2 exh101.htm EXHIBIT 1.01 Exhibit 1.01 UFP Technologies, Inc. Conflict Minerals Report Introduction This Conflict Minerals Report (“CMR”) of UFP Technologies, Inc. (herein referred to as “UFP,” the “Company,” “we,” “us,” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techn |
|
| May 2, 2023 |
UFP Technologies Announces Record Q1 2023 Results EXHIBIT 99.1 UFP Technologies Announces Record Q1 2023 Results NEWBURYPORT, Mass., May 02, 2023 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $9.7 million or $1.27 per diluted common share outstanding for its first quarter ended March 31, 2023, compared to net in |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defi |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☒ Defin |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2023 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| April 24, 2023 |
Exhibit 3.1 SECOND AMENDED AND RESTATED BY-LAWS of UFP TECHNOLOGIES, INC. A Delaware Corporation As amended and restated, effective as of April 24, 2023 /s/ Christopher P. Litterio Christopher P. Litterio, Secretary i SECOND AMENDED AND RESTATED BY-LAWS TABLE OF CONTENTS Page Article I. Stockholders 1 Section 1.1 Annual Meeting. 1 Section 1.2 Special Meetings. 1 Section 1.3 Notice of Meeting. 1 Se |
|
| April 24, 2023 |
STRENGTHENING OUR PLATFORM UNLOCKING NEW OPPORTUNITIES 2022 ANNUAL REPORTUFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. |
|
| April 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) ☐ Defin |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 21, 2023 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File |
|
| March 21, 2023 |
Exhibit 99.1 Welcome Investors March 2022 Welcome Investors March 2023 Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Comp any’s future fin |
|
| March 16, 2023 |
Exhibit 10.33 UFP TECHNOLOGIES, INC. 2003 INCENTIVE PLAN As Amended and Restated on March 14, 2023 1. Statement of Purpose. The purpose of this 2003 Incentive Plan (hereinafter referred to as the “Plan”) is to benefit UFP TECHNOLOGIES, INC. (the “Company”) through the maintenance and development of its businesses by offering equity-based and other incentives to certain present and future executive |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12648 UFP Technologies, Inc. (E |
|
| March 16, 2023 |
Subsidiaries of the Company. * Exhibit 21.01 UFP Technologies, Inc. wholly owns the following companies: 1. Advant Medical Limited, a private limited company incorporated under the laws of Ireland, its wholly-owned subsidiary: a. Munlu Leighis Advant Teoranta, a private limited company incorporated under the laws of Ireland 2. Advant Costa Rica Limitada, incorporated under the laws of Costa Rica 3. Advant Medical Inc., a Delawa |
|
| March 16, 2023 |
Form of 2023 Stock Unit Award Agreement (Dominican Republic). #* Exhibit 10.32 UFP TECHNOLOGIES, INC. 2003 INCENTIVE PLAN As Amended and Restated on March 14, 2023 1. Statement of Purpose. The purpose of this 2003 Incentive Plan (hereinafter referred to as the “Plan”) is to benefit UFP TECHNOLOGIES, INC. (the “Company”) through the maintenance and development of its businesses by offering equity-based and other incentives to certain present and future executive |
|
| March 16, 2023 |
Consent of Grant Thornton LLP. * Exhibit 23.01 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our reports dated March 16, 2023, with respect to the consolidated financial statements and internal controls over financial reporting included in the Annual Report of UFP Technologies, Inc. on Form 10-K for the year ended December 31, 2022. We hereby consent to the incorporation by reference of said reports in t |
|
| March 16, 2023 |
Exhibit 10.31 Exhibit E STOCK UNIT AWARD AGREEMENT (with Ireland Supplement) (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 14th day of February, 2023 by and between UFP Technologies, Inc. (hereinafter the “Company”) and (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them i |
|
| March 16, 2023 |
Exhibit 31.01 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, R. Jeffrey Bailly, President and Chief Executive Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this annual report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| March 16, 2023 |
Exhibit 31.02 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ronald J. Lataille, Chief Financial Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this annual report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make th |
|
| March 16, 2023 |
Exhibit 32.01 CERTIFICATION Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of UFP Technologies, Inc., a Delaware corporation (the “Co |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2023 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| March 10, 2023 |
UFP Technologies Announces Record 2022 Results EXHIBIT 99.1 UFP Technologies Announces Record 2022 Results NEWBURYPORT, Mass., March 07, 2023 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $41.8 million or $5.45 per diluted common share outstanding for its year ended December 31, 2022, compared to net income of $ |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2023 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commissio |
|
| February 21, 2023 |
Exhibit 10.4 Exhibit D STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 14th day of February, 2023 by and between UFP Technologies, Inc. (hereinafter the “Company”) and (the “Awardee”). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company’s 2003 Incent |
|
| February 21, 2023 |
Exhibit 10.1 Exhibit A INCENTIVE STOCK OPTION AGREEMENT INCENTIVE STOCK OPTION AGREEMENT made this 14th day of February 2023 between UFP TECHNOLOGIES, INC., a Delaware corporation (hereinafter called the Corporation), and R. JEFFREY BAILLY, an employee of the Corporation or one or more of its subsidiaries (hereinafter called the Employee). The Corporation desires, by affording the Employee an oppo |
|
| February 21, 2023 |
Exhibit 10.2 Exhibit B NON-QUALIFIED STOCK OPTION AGREEMENT NON-QUALIFED STOCK OPTION AGREEMENT made this 14th day of February 2023 between UFP TECHNOLOGIES, INC., a Delaware corporation (hereinafter called the Corporation), and R. JEFFREY BAILLY, an employee of the Corporation or one or more of its subsidiaries (hereinafter called the Employee). The Corporation desires, by affording the Employee |
|
| February 21, 2023 |
EX-10.3 4 exh103.htm EXHIBIT 10.3 Exhibit 10.3 Exhibit C STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 14th day of February, 2023 by and between UFP Technologies, Inc. (hereinafter the “Company”) and R. Jeffrey Bailly (the “Awardee”). Capitalized terms used but not defined herein shall have the me |
|
| February 14, 2023 |
UFPT / UFP Technologies, Inc. / BAILLY R JEFFREY - SC 13G/A Passive Investment SC 13G/A 1 sc13ga040622.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 21)* UFP Technologies, Inc. (Name of Issuer) Common Stock - $.01 Par Value 902673102 (CUSIP Number) December 31, 2021 Date of Event which requires filing of this statement Check the appropriate box to designate the rule p |
|
| February 13, 2023 |
UFPT / UFP Technologies, Inc. / RENAISSANCE TECHNOLOGIES LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14)* UFP Technologies, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) December 30, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 10, 2023 |
UFPT / UFP Technologies, Inc. / Neuberger Berman Group LLC - NONE Passive Investment SC 13G 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* UFP TECHNOLOGIES INC (Name of Issuer) COMMON (Title of Class of Securities) 902673102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| February 1, 2023 |
UFPT / UFP Technologies, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us9026731029020123.txt us9026731029020123.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) UFP TECHNOLOGIES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| January 19, 2023 |
UFPT / UFP Technologies, Inc. / AltraVue Capital, LLC Passive Investment SC 13G/A 1 UFPT13GAnnual12312022.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* UFP Technologies, Inc. (Name of Issuer) Common (Title of Class of Securities) 902673102 (CUSIP Number) December 31st, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate |
|
| November 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 15, 2022 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission Fi |
|
| November 15, 2022 |
Exhibit 99.1 Welcome Investors November 16, 2022 Forward Looking Statements 2 Certain statements in this presentation may be considered ?forward - looking statements? within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Comp any?s future financial or operating pe |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Num |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP T |
|
| November 4, 2022 |
UFP Technologies Announces Record Q3 2022 Results EXHIBIT 99.1 UFP Technologies Announces Record Q3 2022 Results NEWBURYPORT, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $19.5 million or $2.56 per diluted common share outstanding for its third quarter |
|
| November 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2022 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| September 20, 2022 |
Exhibit 99.1 Welcome Investors September 21, 2022 Forward Looking Statements 2 Certain statements in this presentation may be considered ?forward - looking statements? within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Comp any?s future financial or operating p |
|
| September 20, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): September 20, 2022 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission F |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techno |
|
| August 3, 2022 |
UFP Technologies Announces Record Q2 Results EXHIBIT 99.1 UFP Technologies Announces Record Q2 Results NEWBURYPORT, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $8.9 million or $1.17 per diluted common share outstanding for its second quarter ende |
|
| August 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| June 16, 2022 |
Calculation of Filing Fee Table (filed herewith) Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) UFP Technologies, Inc. |
|
| June 16, 2022 |
As filed with the Securities and Exchange Commission on June 16, 2022 As filed with the Securities and Exchange Commission on June 16, 2022 Registration No. |
|
| June 16, 2022 |
Power of Attorney (filed herewith) EX-24 4 exh24.htm EXHIBIT 24 Exhibit 24 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned, being a director or officer, or both, of UFP Technologies, Inc., a Delaware corporation (hereinafter called the “Corporation”), does hereby constitute and appoint Jeffrey Bailly, Ronald J. Lataille and Patrick J. Kinney, Jr., and each of them, his or her true and lawful attorney- |
|
| June 14, 2022 |
Exhibit 3.01 RESTATED CERTIFICATE OF INCORPORATION OF UFP TECHNOLOGIES, INC. (Pursuant to Sections 245 of the General Corporation Law of the State of Delaware) UFP Technologies, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the ?General Corporation Law?), DOES HEREBY CERTIFY: 1. That the name of this corpor |
|
| June 14, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 14, 2022 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File N |
|
| June 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2022 UFP TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 14, 2022 |
Exhibit 10.01 UFP TECHNOLOGIES, INC. 2009 NON-EMPLOYEE DIRECTOR STOCK INCENTIVE PLAN (as amended on March 8, 2022) 1. Statement of Purpose. The purpose of this 2009 Non-Employee Director Stock Incentive Plan (formerly known as the 1998 Director Stock Option Incentive Plan and hereinafter referred to as the ?Plan?) is to benefit non-employee members of the Board of Directors of UFP TECHNOLOGIES, IN |
|
| June 14, 2022 |
Exhibit 99.1 Welcome Investors June 16, 2022 Forward Looking Statements 2 Certain statements in this presentation may be considered ?forward - looking statements? within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events or the Comp any?s future financial or operating perfor |
|
| May 24, 2022 |
Exhibit 1.01 UFP Technologies, Inc. Conflict Minerals Report Introduction This Conflict Minerals Report (?CMR?) of UFP Technologies, Inc. (herein referred to as ?UFP,? the ?Company,? ?we,? ?us,? or ?our?) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2021 to December 31, 2021 (the ?Re |
|
| May 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 100 Hale Street, Newburyport Massachusetts 01950 (Address of Principal Ex |
|
| May 11, 2022 |
DEFR14A 1 defr14a051122.htm DEFR14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as p |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techn |
|
| May 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| May 9, 2022 |
UFP Technologies Announces Strong Q1 2022 Results EXHIBIT 99.1 UFP Technologies Announces Strong Q1 2022 Results NEWBURYPORT, Mass., May 04, 2022 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $4.9 million or $0.64 per diluted common share outstanding for its first quarter e |
|
| May 4, 2022 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 UFP Technologies, Inc. |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ? ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Def |
|
| April 6, 2022 |
UFPT / UFP Technologies, Inc. / BAILLY R JEFFREY - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 21)* UFP Technologies, Inc. (Name of Issuer) Common Stock - $.01 Par Value 902673102 (CUSIP Number) December 31, 2021 Date of Event which requires filing of this statement Check the appropriate box to designate the rule pursuant to which this schedule is fil |
|
| March 17, 2022 |
UFP Technologies, Inc. Acquires Advant Medical Ltd. EXHIBIT 99.1 UFP Technologies, Inc. Acquires Advant Medical Ltd. NEWBURYPORT, Mass., March 17, 2022 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Advant Medical Ltd. Founded in 1993 and headquartered in Galway, Ireland |
|
| March 17, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2022 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| March 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-12648 UFP Technologies, Inc. (E |
|
| March 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2022 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| March 14, 2022 |
Exhibit 32.01 CERTIFICATION Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of UFP Technologies, Inc., a Delaware corporation (the “Co |
|
| March 14, 2022 |
Consent of Grant Thornton LLP. * Exhibit 23.01 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our reports dated March 14, 2022, with respect to the consolidated financial statements and internal controls over financial reporting included in the Annual Report of UFP Technologies, Inc. on Form 10-K for the year ended December 31, 2021. We hereby consent to the incorporation by reference of said reports in t |
|
| March 14, 2022 |
Exhibit 31.02 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Ronald J. Lataille, Chief Financial Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this annual report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make th |
|
| March 14, 2022 |
Exhibit 31.01 Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, R. Jeffrey Bailly, President and Chief Executive Officer of UFP Technologies, Inc., certify that: 1. I have reviewed this annual report on Form 10-K of UFP Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| March 14, 2022 |
Subsidiaries of the Company. * Exhibit 21.01 UFP Technologies, Inc. wholly owns the following companies: 1. Moulded Fibre Technology, Inc., a Maine company 2. Simco Industries, Inc., a Michigan company 3. Dielectrics, Inc., a Massachusetts company 4. Contech Medical, Inc., a Rhode Island company 5. DAS Medical Holdings, LLC, a Georgia limited liability company, and its wholly-owned subsidiaries: a. Sterimed, LLC, a Georgia limi |
|
| March 14, 2022 |
UFP Technologies Announces 2021 Results EXHIBIT 99.1 UFP Technologies Announces 2021 Results NEWBURYPORT, Mass., March 08, 2022 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $15.9 million or $2.09 per diluted common share outstanding for its year ended December 31 |
|
| March 10, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2021 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commiss |
|
| March 10, 2022 |
DAS Medical Holdings, LLC and Subsidiaries Consolidated Financial Statements December 31, 2020 Exhibit 99.1 DAS Medical Holdings, LLC and Subsidiaries Consolidated Financial Statements December 31, 2020 DAS Medical Holdings, LLC and Subsidiaries Table of Contents December 31, 2020 Independent Auditor?s Report 1 Consolidated Financial Statements Consolidated Balance Sheet 3 Consolidated Statement of Income 4 Consolidated Statement of Changes in Members? Equity 5 Consolidated Statement of Cas |
|
| March 10, 2022 |
Exhibit 99.3 UFP Technologies, Inc. Unaudited Pro Forma Condensed Combined Financial Statements The following unaudited pro forma condensed combined financial statements are provided for informational purposes only and do not purport to represent what the actual combined results of operations or the combined financial position of the combined company would be had the acquisition occurred on the da |
|
| March 10, 2022 |
Exhibit 99.2 DAS Medical Holdings, LLC and Subsidiaries Consolidated Financial Statements (unaudited) As of September 30, 2021 and 2020 and for each of the three and nine months ended September 30, 2021 and 2020 Unaudited Consolidated Financial Statements Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Income 4 Condensed Consolidated Statement of Changes in Members? Eq |
|
| February 22, 2022 |
Exhibit 10.2 Exhibit B STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 15th day of February, 2022 by and between UFP Technologies, Inc. (hereinafter the ?Company?) and (the ?Awardee?). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Company?s 2003 Incent |
|
| February 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 15, 2022 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commissio |
|
| February 22, 2022 |
Exhibit 10.1 Exhibit A STOCK UNIT AWARD AGREEMENT (Granted under the UFP Technologies, Inc. 2003 Incentive Plan) This Stock Unit Award Agreement is entered into as of the 15th day of February, 2022 by and between UFP Technologies, Inc. (hereinafter the ?Company?) and R. Jeffrey Bailly (the ?Awardee?). Capitalized terms used but not defined herein shall have the meanings assigned to them in the Com |
|
| February 14, 2022 |
UFPT / UFP Technologies, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 11, 2022 |
UFPT / UFP Technologies, Inc. / RENAISSANCE TECHNOLOGIES LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* UFP Technologies, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 8, 2022 |
UFPT / UFP Technologies, Inc. / AltraVue Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* UFP Technologies, Inc. (Name of Issuer) Common (Title of Class of Securities) 902673102 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu |
|
| February 1, 2022 |
UFPT / UFP Technologies, Inc. / BlackRock Inc. Passive Investment us9026731029020122.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) UFP TECHNOLOGIES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 902673102 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| December 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2021 UFP Technologies, Inc. |
|
| December 23, 2021 |
UFP Technologies Acquires DAS Medical EXHIBIT 99.1 UFP Technologies Acquires DAS Medical NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufactu |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2021 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| December 23, 2021 |
EXHIBIT 10.3 SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of December 22, 2021 among UFP TECHNOLOGIES, INC., as Borrower, CERTAIN SUBSIDIARIES OF UFP TECHNOLOGIES, INC. PARTY HERETO, as Guarantors, BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and THE LENDERS PARTY HERETO BANK OF AMERICA, N.A., as Sole Lead Arranger and Sole Bookrunner TABLE OF CONTENTS |
|
| December 23, 2021 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is made as of December 22, 2021 (the ?Signing Date?), by and among UFP Technologies, Inc., a Delaware corporation (?Buyer?), DAS Medical Holdings LLC, a Georgia limited liability company (the ?Company?), Parallax Investments, LLC, a Georgia limited liability company (?Seller?), and the Purchase Price B |
|
| December 23, 2021 |
EXHIBIT 10.2 PERSONAL GOODWILL PURCHASE AND SALE AGREEMENT This Personal Goodwill Purchase and Sale Agreement (this "Agreement") is made as of December 22, 2021 (the ?Closing Date?) by and among UFP Technologies, Inc., a Delaware corporation having an office in Massachusetts at 100 Hale Street, Newburyport, Massachusetts 01950 ("Buyer"), Danny R. Lee, a resident of Florida (?Danny?), Daniel Lee, a |
|
| November 5, 2021 |
Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this ?Agreement?) is made as of October 21, 2021 (the ?Effective Date?), by and among UFP Technologies, Inc., a Delaware corporation (?Buyer?), Contech Medical, Inc., a Rhode Island corporation (the ?Company?), and all of the Company?s shareholders, the names of which are set forth on the signature pages to this Agreement (collec |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP T |
|
| October 13, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2021 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission |
|
| October 13, 2021 |
UFP Technologies, Inc. Acquires Contech Medical, Inc. EXHIBIT 99.1 UFP Technologies, Inc. Acquires Contech Medical, Inc. NEWBURYPORT, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Contech Medical, Inc. Founded in 1987 and headquartered in Providence, |
|
| September 21, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): September 21, 2021 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission F |
|
| September 21, 2021 |
Exhibit 99.1 Welcome Investors September 2021 Safe Harbor Statement This presentation contains forward - looking information that involves risks and uncertainties, including statements about the Company?s prospects, anticipated advantages the Company expects to realize from its acquisition strategies, the Company?s financial performance, targets, goals, and metrics, participation in multiple marke |
|
| September 7, 2021 |
UFPT / UFP Technologies, Inc. / AltraVue Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* UFP Technologies, Inc. (Name of Issuer) Common (Title of Class of Securities) 902673102 (CUSIP Number) September 1, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| August 25, 2021 |
Exhibit 99.1 Welcome Investors August 2021 Safe Harbor Statement This presentation contains forward - looking information that involves risks and uncertainties, including statements about the Company?s prospects, anticipated advantages the Company expects to realize from its acquisition strategies, the Company?s financial performance, targets, goals, and metrics, participation in multiple markets, |
|
| August 25, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 25, 2021 UFP Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File |
|
| August 13, 2021 |
EX-10.1 2 exh101.htm EXHIBIT 10.1 Exhibit 10.1 LEASE AGREEMENT CONTRATO DE ARRENDAMIENTO LEASE AGREEMENT ENTERED INTO BY AND BETWEEN LOGISTICA INDUSTRIAL DE TIJUANA ESTE, S.A. DE C.V., REPRESENTED BY MR. CARLOS ALBERTO JARAMILLO SILVA, (HEREINAFTER REFERRED TO AS THE ¨LESSOR¨), AND BY CO PRODUCTION DE TIJUANA, S.A. DE C.V., REPRESENTED BY MR. ROMAN ALONSO CASO ESPINOSA (HEREINAFTER REFERRED TO AS |
|
| August 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2021 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commission F |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techno |
|
| August 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2021 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| August 5, 2021 |
UFP Technologies Announces Strong Q2 2021 Results EXHIBIT 99.1 UFP Technologies Announces Strong Q2 2021 Results NEWBURYPORT, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) - UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $4.7 million or $0.62 per diluted common share outstanding for its second quarter |
|
| June 15, 2021 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 Welcome Investors June 2021 Safe Harbor Statement This presentation contains forward - looking information that involves risks and uncertainties, including statements about the Company’s prospects, anticipated advantages the Company expects to realize from its acquisition strategies, the Company’s financial performance, targets, goals, and metrics, pa |
|
| June 15, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 15, 2021 UFP TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-12648 04-2314970 (Commission File N |
|
| June 14, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2021 UFP TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 28, 2021 |
EX-1.01 2 exh101.htm EXHIBIT 1.01 Exhibit 1.01 UFP Technologies, Inc. Conflict Minerals Report INTRODUCTION This Conflict Minerals Report (“CMR”) of UFP Technologies, Inc. (herein referred to as “UFP,” the “Company,” “we,” “us,” or “our”) has been prepared pursuant to Rule 13p-1 and Form SD promulgated under the Securities Exchange Act of 1934 for the reporting period from January 1, 2020 to Decem |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-12648 04-2314970 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 100 Hale Street, Newburyport Massachusetts 01950 (Address of Principal Ex |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12648 UFP Techn |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ? ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Def |
